1. EU. Commission Regulation (EC) No 149/2008 of 29 January 2008 amending Regulation (EC) No 396/2005 of the European Parliament and of the Council by establishing Annexes II, III and IV setting maximum residue levels for products covered by Annex I. Available: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32008R0149:EN:NOT (accessed 09.01.14).
2. Review report for the active substance thiabendazole. Finalised in the Standing Committee on Plant Health at its meeting on 12 December 2000 in view of the inclusion of thiabendazole in Annex I of Directive 91/414/EEC, 7603/VI/97-final;EU,2001
3. Use of benzimidazole chemotherapy in human helminthiases: Indications and efficacy
4. Randomized Clinical Trial on Ivermectin versus Thiabendazole for the Treatment of Strongyloidiasis